Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.

Slama L, Palella FJ Jr, Abraham AG, Li X, Vigouroux C, Pialoux G, Kingsley L, Lake JE, Brown TT; on behalf of the Multicenter AIDS Cohort Study (MACS); on behalf of the Multicenter AIDS Cohort Study MACS.

J Antimicrob Chemother. 2014 Aug 4. pii: dku295. [Epub ahead of print]

PMID:
25096078
[PubMed - as supplied by publisher]
2.

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Palella FJ Jr, Armon C, Buchacz K, Chmiel JS, Novak RM, D'Aquila RT, Brooks JT; on behalf of the HOPS Investigators.

J Antimicrob Chemother. 2014 Jun 16. pii: dku190. [Epub ahead of print]

PMID:
24942257
[PubMed - as supplied by publisher]
3.

Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.

Brener M, Ketlogetswe K, Budoff M, Jacobson LP, Li X, Rezaeian P, Razipour A, Palella FJ Jr, Kingsley L, Witt MD, George RT, Post WS.

AIDS. 2014 May 7. [Epub ahead of print]

PMID:
24809732
[PubMed - as supplied by publisher]
4.

Associations between HIV infection and subclinical coronary atherosclerosis.

Post WS, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Brown TT, Jacobson LP.

Ann Intern Med. 2014 Apr 1;160(7):458-67. doi: 10.7326/M13-1754.

PMID:
24687069
[PubMed - indexed for MEDLINE]
5.

HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.

Ng DK, Jacobson LP, Brown TT, Palella FJ Jr, Martinson JJ, Bolan R, Miller ER 3rd, Schwartz GJ, Abraham AG, Estrella MM.

AIDS. 2014 Jan 28;28(3):377-86. doi: 10.1097/QAD.0000000000000094.

PMID:
24670523
[PubMed - in process]
6.

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.

Palella FJ Jr, Fisher M, Tebas P, Gazzard B, Ruane P, Van Lunzen J, Shamblaw D, Flamm J, Ebrahimi R, Porter D, White K, Hindman J, Elbert E, De-Oertel S, Fralich T.

AIDS. 2014 Jan 28;28(3):335-44. doi: 10.1097/QAD.0000000000000087.

PMID:
24670520
[PubMed - in process]
7.

Risk factors for fatty liver in the Multicenter AIDS Cohort Study.

Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ Jr, Witt MD, Post WS, Thio CL.

Am J Gastroenterol. 2014 May;109(5):695-704. doi: 10.1038/ajg.2014.32. Epub 2014 Mar 18.

PMID:
24642579
[PubMed - indexed for MEDLINE]
8.

Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.

Margolick JB, Jacobson LP, Schwartz GJ, Abraham AG, Darilay AT, Kingsley LA, Witt MD, Palella FJ Jr.

PLoS One. 2014 Feb 7;9(2):e86311. doi: 10.1371/journal.pone.0086311. eCollection 2014.

PMID:
24516530
[PubMed - in process]
Free PMC Article
9.

Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr; Multicenter AIDS cohort Study.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):57-64. doi: 10.1097/QAI.0b013e3182a99a0d.

PMID:
24419062
[PubMed - indexed for MEDLINE]
10.

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.

Ketlogetswe KS, Post WS, Li X, Palella FJ Jr, Jacobson LP, Margolick JB, Kingsley LA, Witt MD, Dobs AS, Budoff MJ, Brown TT.

AIDS. 2014 Mar 27;28(6):901-9. doi: 10.1097/QAD.0000000000000186.

PMID:
24401646
[PubMed - in process]
Free PMC Article
11.

Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.

Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT; HIV Outpatient Study Investigators.

Antivir Ther. 2013;18(1):65-75. doi: 10.3851/IMP2450. Epub 2012 Oct 30.

PMID:
23111762
[PubMed - indexed for MEDLINE]
12.

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.

Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT; HOPS Investigators.

AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.

PMID:
21811144
[PubMed - indexed for MEDLINE]
13.

Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.

Estrella MM, Parekh RS, Astor BC, Bolan R, Evans RW, Palella FJ Jr, Jacobson LP.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):380-6. doi: 10.1097/QAI.0b013e318222f461.

PMID:
21646913
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cardiovascular disease in HIV infection.

Palella FJ Jr, Phair JP.

Curr Opin HIV AIDS. 2011 Jul;6(4):266-71. doi: 10.1097/COH.0b013e328347876c. Review.

PMID:
21546831
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Low incidence of renal impairment observed in tenofovir-treated patients.

O'Donnell EP, Scarsi KK, Darin KM, Gerzenshtein L, Postelnick MJ, Palella FJ Jr.

J Antimicrob Chemother. 2011 May;66(5):1120-6. doi: 10.1093/jac/dkr039. Epub 2011 Feb 17.

PMID:
21393145
[PubMed - indexed for MEDLINE]
Free Article
16.

Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.

Palella FJ Jr, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, Elion R.

AIDS. 2010 Jul 17;24(11):1657-65. doi: 10.1097/QAD.0b013e3283389dfa.

PMID:
20588104
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.

Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators.

AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.

PMID:
20502317
[PubMed - indexed for MEDLINE]
18.

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.

Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella FJ Jr, Hook EW 3rd.

J Clin Microbiol. 2010 May;48(5):1827-32. doi: 10.1128/JCM.02398-09. Epub 2010 Mar 24.

PMID:
20335410
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.

Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT; HOPS (HIV Outpatient Study) Investigators.

Ann Intern Med. 2009 Jul 21;151(2):73-84.

PMID:
19620160
[PubMed - indexed for MEDLINE]
20.

Severe rhabdomyolysis associated with raltegravir use.

Zembower TR, Gerzenshtein L, Coleman K, Palella FJ Jr.

AIDS. 2008 Jul 11;22(11):1382-4. doi: 10.1097/QAD.0b013e328303be40. No abstract available.

PMID:
18580624
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk